UGA study documents lung function declines in firefighters working at prescribed burns

After monitoring firefighters working at prescribed burns in the southeastern U.S., University of Georgia researchers found that lung function decreased with successive days of exposure to smoke and other particulate matter.

"What we found suggested a decline in lung function across work seasons," said Olorunfemi Adetona, a postdoctoral research associate and lead author of the study published recently in the journal Inhalation Toxicology.

Luke Naeher, senior author and associate professor in the UGA College of Public Health, explained that the study was designed to investigate whether the 26 experienced a decrease in lung function working at compared with days they spent away from the fires. Previously, researchers had looked only at changes in lung function of wildland firefighters on days with exposure to smoke.

"Over a 10-week season, these workers' respiratory functions slowly declined," Naeher said, adding that there is need to investigate the degree to which these declines returned to their baseline after the burn season. Although results of the study show that lung function at the start of two burn seasons in a limited number of nine firefighters in 2003 and 2004 did not vary significantly, more definitive answers relating to the issue of longer term effect of exposure on would require a different study design.

In recent years, the U.S. has sought to better understand and improve its occupational exposure limits for firefighters across the country. Most studies have concentrated on burns in Western states where exposure to and composition of wood-smoke may vary to some degree when compared with fires in the Southeast, including South Carolina, where the study was done.

Naeher said the study provides some preliminary information regarding the of exposure that is intermediate between two exposure extremes. On the low extreme lie ambient air levels typical for developed countries, while inhalation of particles by a smoker represents the opposite extreme. Much research in the field has focused on health effects at both extremes. However, the study of exposure at intermediate levels, like that experienced by wildland firefighters, and women and children exposed to indoor air pollution from cook stoves in developing countries is limited. Naeher's research focuses on these two different populations, and he explains that the study of the body's response to these intermediate exposures may now be more urgent. For example, Naeher said, an initiative led by the United Nations Foundation aims to put clean-burning cooking stoves in 100 million homes in developing countries by 2020.

add to favorites email to friend print save as pdf

Related Stories

Study raises concerns about outdoor second-hand smoke

Nov 18, 2009

Indoor smoking bans have forced smokers at bars and restaurants onto outdoor patios, but a new University of Georgia study in collaboration with the Centers for Disease Control and Prevention suggests that these outdoor smoking ...

Recommended for you

Taxing unhealthy food spurs people to buy less

4 hours ago

Labeling foods and beverages as less-healthy and taxing them motivates people to make healthier choices, finds a recent study in the American Journal of Preventive Medicine. When faced with a 30 percent tax on ...

User comments

More news stories

Validating maps of the brain's resting state

Kick back and shut your eyes. Now stop thinking. You have just put your brain into what neuroscientists call its resting state. What the brain is doing when an individual is not focused on the outside world ...

Antioxidant shows promise in Parkinson's disease

Diapocynin, a synthetic molecule derived from a naturally occurring compound (apocynin), has been found to protect neurobehavioral function in mice with Parkinson's Disease symptoms by preventing deficits in motor coordination.

No danger of cancer through gene therapy virus

In fall 2012, the European Medicines Agency (EMA) approved the modified adeno-associated virus AAV-LPL S447X as the first ever gene therapy for clinical use in the Western world. uniQure, a Dutch biotech company, had developed ...